Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

Mostrar otras versiones (1)

Individuals infected with SARS-CoV-2 who also display hyperglycemia suffer from longer hospital stays, higher risk of developing acute respiratory distress syndrome (ARDS), and increased mortality. Nevertheless, the pathophysiological mechanism of hyperglycemia in COVID-19 remains poorly characteriz...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiterer, Moritz, Rajan, Mangala, Gómez-Banoy, Nicolás, Lau, Jennifer D., Gomez-Escobar, Luis G., Ma, Lunkun, Gilani, Ankit, Alvarez-Mulett, Sergio, Sholle, Evan T., Chandar, Vasuretha, Bram, Yaron, Hoffman, Katherine, Bhardwaj, Priya, Piloco, Phoebe, Rubio-Navarro, Alfonso, Uhl, Skyler, Carrau, Lucia, Houhgton, Sean, Redmond, David, Shukla, Alpana P., Goyal, Parag, Brown, Kristy A., tenOever, Benjamin R., Alonso, Laura C., Schwartz, Robert E., Schenck, Edward J., Safford, Monika M., Lo, James C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Clinical and Translational Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443335/
https://www.ncbi.nlm.nih.gov/pubmed/34599884
http://dx.doi.org/10.1016/j.cmet.2021.09.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443335/
https://www.ncbi.nlm.nih.gov/pubmed/34599884
http://dx.doi.org/10.1016/j.cmet.2021.09.009

Ejemplares similares